*.*.44.201
药智数据企业版
量身打造,体验升级
立即前往
VIP免费试用申请
登录 注册
当前位置: 首页 > 日本上市新药 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-

1.本库的“新药”是指日本上市的用于医疗用途的含有新活性成分药物,新药组合药物,新给药途径药物,新适应药物,新药物类型药物,新剂量药物等药物。


2.更多信息访问 日本上市药品数据库

你目前无法使用部分二次筛选功能 请联系客服开通更多权限和功能!
商标名 通用名称(日文) 通用名称(英文) 通用名称(中文) 申请公司 申请类型 批准日期 备注 类型 特殊审批
查看 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Change 2016-03-18 A drug with a new additional pediatric dosage indicated for the prevention of pandemic influenza (H5N1). [Orphan drug] 查看 查看
查看 Takeda Pharmaceutical Company Limited Approval 2013-06-18 Drugs with a new active ingredient indicated for theprevention of pandemic influenza (H5N1).[Orphan drug] 查看 查看
查看 Takeda Pharmaceutical Company Limited Approval 2013-06-18 Drugs with a new active ingredient indicated for theprevention of pandemic influenza (H5N1).[Orphan drug] 查看 查看
查看 Takeda Pharmaceutical Company Limited Approval 2013-04-26 Drugs with a new active ingredient indicated for theprevention of pandemic influenza.[Orphan drug] 查看 查看
查看 Takeda Pharmaceutical Company Limited Approval 2013-04-26 Drugs with a new active ingredient indicated for theprevention of pandemic influenza.[Orphan drug] 查看 查看
查看 Denka Seiken Co., Ltd. Approval 2013-03-25 A drug with a new active ingredient indicated forthe prevention of pandemic influenza (H5N1).[Orphan drug] 查看 查看
查看 Kaketsuken [The Chemo-Sero-TherapeuticResearch Institute] Approval 2010-10-27 A drug with a new active ingredient indicated forthe prevention of pandemic influenza (H5N1).[Orphan drug] 查看 查看
查看 The Research Foundation forMicrobial Diseases of OsakaUniversity Approval 2007-11-19 A drug containing a new active ingredientindicated for the prevention of pandemicinfluenza (H5N1).[Orphan drug] 查看 查看
查看 The Kitasato Institute Approval 2007-11-19 A drug containing a new active ingredientindicated for the prevention of pandemicinfluenza (H5N1).[Orphan drug] 查看 查看